Vaccines & Disease · Diphtheria

Diphtheria disease & vaccine quick facts

Published November 8, 2021 · 2 min read
01

Diphtheria Quick Facts

  • Respiratory diphtheria is a rare bacterial infection with symptoms occurring 2-5 days after exposure. Symptoms include a sore throat, croupy cough, low-grade fever, runny nose, breathing problems, and a fiber-like coating on the tonsils, pharynx, or inside of the nose. Neck swelling (bull neck) is usually present in severe disease.1 Complications include heart inflammation (myocarditis), neurologic inflammation (neuritis), kidney damage, and airway obstruction. Death occurs in 5-10 percent of respiratory cases.2
  • Cutaneous diphtheria presents as infected skin lesions that lack a uniform appearance. It is most frequently seen in the tropics or among persons experiencing homelessness. Complications occur less often from this form of diphtheria.3
  • Diphtheria is contagious and spreads from person to person through respiratory secretions (coughing, sneezing). It can also be transmitted if a person touches the wound of a person with diphtheria or from touching objects contaminated with the bacteria.4 Vaccinated individuals can still spread the bacteria because vaccination does not eliminate the carriage of Corynebacterium diphtheriae in the back of the throat or on the skin.5
  • Treatment options for diphtheria include using the diphtheria antitoxin and antibiotics to target the infection.6
  • While diphtheria is extremely rare in the U.S. and other developed countries with good sanitation,7 it is still endemic in various areas of the world, including Eastern Europe, the Middle East, Asia, the South Pacific, and countries such as Haiti, the Dominican Republic, and Venezuela.8
02

Diphtheria Vaccine Quick Facts

  • There are 11 different diphtheria-containing (combination) vaccines licensed for use in the United States, which may also include one or more of the following vaccines – pertussis, tetanus, hepatitis B, Hib, and/or polio. Seven diphtheria combination vaccines available for use in infants and children and four are available for adults.9
  • Adverse reactions to combination vaccines containing diphtheria include a temperature of 105F or higher, collapse/shock, persistent crying, convulsions, coma, uncontrolled epilepsy, progressive encephalopathy, and death.1011
  • Vaccinated individuals can still spread the diphtheria bacteria because vaccination does not eliminate the carriage of Corynebacterium diphtheriae in the back of the throat or on the skin.12
  • As of January 2, 2026, there have been 224,536 adverse events reported to the Vaccine Adverse Events Reporting System (VAERS) in connection with diphtheria and diphtheria-containing vaccines combined with additional vaccines since 1990, including 3,555 related deaths, 26,898 hospitalizations, and 3,961 related disabilities. Some of the adverse reactions of the combination vaccines containing diphtheria include a temperature of 105 F. or higher, collapse or shock-like state (hypotonic-hyporesponsive episodes), persistent crying lasting 3 hours or more, convulsions with or without fever, and encephalopathy (coma, decreased level of consciousness, prolonged convulsions).
  • As of December 1, 2025, there had been 6,749 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following diphtheria vaccination, including 886 deaths and 5,863 serious injuries.
Food & Drug Administration (FDA)

IMPORTANT NOTE: NVIC encourages you to become fully informed about Diphtheria and the Diphtheria vaccine by reading all sections in the Table of Contents, which contain many links and resources such as the manufacturer product information inserts, and to speak with one or more trusted health care professionals before making a vaccination decision for yourself or your child. This information is for educational purposes only and is not intended as medical advice.

References
  1. 1Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Diphtheria. 14th ed. Centers for Disease Control (CDC) Apr. 23, 2024.
  2. 2Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Diphtheria. 14th ed. Centers for Disease Control (CDC) Apr. 23, 2024.
  3. 3Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Diphtheria. 13th ed. Centers for Disease Control (CDC) Apr. 23, 2024.
  4. 4US Centers for Disease Control and Prevention. How it spreads. Feb. 12, 2024.
  5. 5Mayo Clinic. Symptoms. Oct. 6, 2023.
  6. 6US Centers for Disease Control and Prevention. Clinical Guidance for Diptheria. Feb. 12, 2024.
  7. 7Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Diphtheria. 14th ed. Centers for Disease Control (CDC) Apr. 23, 2024.
  8. 8US Centers for Disease Control and Prevention. Chapter 4 – Diphtheria. Oxford University Press May 1, 2023.
  9. 9US Food and Drug Administration. Vaccines Licensed for Use in the United States. May 31, 2024.
  10. 10US Centers for Disease Control and Prevention. DTaP (Diphtheria, Tetanus, Pertussis) VIS. Aug. 6, 2021.
  11. 11US Centers for Disease Control and Prevention. Tdap (Tetanus, Diphtheria, Pertussis) VIS. Aug. 6, 2021.
  12. 12Communication and Education Branch, National Center for Immunization and Respiratory Diseases (NCIRD) and the Centers for Disease Control (CDC). Chapter 1: Diphtheria. Centers for Disease Control (CDC) Dec. 13, 2022.
Select disease / vaccine